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Abstract 
Hypertrophic osteoarthropathy (HOA) char-
acterised by arthralgia, clubbing and periosteal
proliferation of long bones, is rarely encoun-
tered in children and adolescents. Whereas in
adults over 80% of cases are associated with
malignancy, in children the majority of cases
are due to non-neoplastic causes such as cys-
tic fibrosis, bilary atresia and congenital heart
disease. Up to 5% of adults with lung cancer
demonstrate signs of HOA. However, lung can-
cer is extremely uncommon in children and
young people. Here we report a case of lung
adenocarcinoma in an 18 year old male associ-
ated with HOA present both at diagnosis and at
subsequent disease progression. 
Introduction 
Hypertrophic  osteoarthropathy  (HOA)  is  a
syndrome  characterised  by  digital  clubbing,
polyarthritis and periosteal new bone forma-
tion of the long bones.1Lung cancer, a common
cause of HOA in adults, is rarely encountered
in children and adolescents. Whilst adenocar-
cinoma and squamous cell carcinoma are the
most  common  histological  subtypes  seen  in
adults, bronchial carcinoid accounts for up to
80% of childhood lung cancers.2Here we report
an unusual case of aggressive lung adenocar-
cinoma in an 18 year old male in which HOA
was a disabling symptom. 
Case Report
An 18 year old Caucasian male gave a six
week  history  of  progressive  breathlessness
and left sided chest pain. He had also noticed
increasing  pain  and  swelling  of  his  finger
joints. The patient reported no significant past
medical history or family history and was not
taking any regular medication. He had smoked
up to five cigarettes a day for the previous two
years and worked as a plumber, although there
was  no  history  of  asbestos  exposure.  He
attended his local emergency department and
was diagnosed with pneumonia with an asso-
ciated pleural effusion. Intravenous antibiotics
were administered and a pleural tap was per-
formed.  Pleural  fluid  revealed  a  transudate
with no malignant cells. Following drainage of
the effusion his symptoms improved and he
was discharged. He returned one week later
with worsening dyspnoea, vomiting and wide-
spread  arthralgia,  particularly  affecting  the
upper limb. He was admitted for further inves-
tigations.
Serum  haematology,  renal,  bone  and  liver
profiles were normal. He had an elevated C-
reactive  protein  (150  mg/L,  normal  range 
<6  mg/L).  Serum  tumour  markers  including
AFP, βHCG and CEA were within the normal
range. An HIV test was negative. A chest x-ray
demonstrated  reaccumulation  of  the  pleural
fluid and a large pleural based mass involving
the left hemi-thorax. CT scan confirmed a large
left sided pleural mass with an associated pleu-
ral  effusion  and  mediastinal  shift.  No  other
sites of disease were identified. Video-assisted
thoracoscopic  surgery  (VATS)  and  a  biopsy
were performed. He was then transferred to our
institution for further management. 
On examination he had reduced air entry
throughout the left lung with a chest drain in
situ  draining  blood  stained  fluid.  Marked
swelling of the interphalangeal and metacar-
pophalangeal  joints  was  noted.  The  patient
demonstrated  clubbing  of  the  fingers.  The
remainder of the examination was unremark-
able. Further staging investigations were then
performed;  a  PET-CT  (Figure  1)  showed  an
extensive and irregular FDG avid mass within
the left hemithorax extending from the apex
towards the diaphragm, which appeared to be
pleural  based,  extending  towards  the  medi-
astinum and abutting the pericardium. A lytic
lesion was also seen within the 10th thoracic
vertebrae.  A  bone  scan  (Figure  2)  did  not
reveal any discrete metastasis; however there
was prominent uptake of tracer throughout the
bone marrow with marked periosteal uptake of
tracer, consistent with a diagnosis of hyper-
trophic osteoarthropathy (HOA). Review of the
biopsy material demonstrated a poorly differ-
entiated adenocarcinoma with numerous atyp-
ical mitosis. Immunohistochemistry revealed
diffuse positivity for EMA, MNF116 and Ber-
EP4. Staining was negative for TTF-1, calre-
tinin, thrombomodulin, CK5/6, CD34, desmin,
SMA, CD30, CD45, AFP and βHCG. 
A diagnosis of poorly differentiated adeno-
carcinoma  of  the  lung  with  associated  HOA
was made. The patient commenced treatment
with  cisplatin  (80  mg/m2 day  1)  and  gemc-
itabine (1250 mg/m2day 1 and 8) every 21 days.
After  one  cycle  of  chemotherapy  he  noticed
resolution of his joint aches and swelling and
was able to discontinue all analgesics. A CT
scan  performed  after  three  cycles  of
chemotherapy  demonstrated  a  partial
response. Unfortu  nately after the fourth cycle
of chemotherapy the patient noticed a return
of his joint pain and swelling and worsening
left  sided  pleuritic  chest  pain.  Imaging  con-
firmed disease progression. The disease con-
tinued  to  progress  despite  sequential  treat-
ment  with  erlotonib,  docetaxel,  carbo  -
platin/paclitaxel (introduced after an allergic
reaction  to  docetaxel)  and  cisplatin/vinorel-
bine and he died from his disease 7 months
after his original diagnosis.
Discussion
Primary  lung  carcinoma  in  childhood  and
adolescence is exceedingly rare and comprises
only 0.2% of all childhood malignancies,3 with
an incidence of approximately one case per 2
million under 19 years old.4 Metastases from
non  pulmonary  tumours  outnumber  primary
lung cancers in children and adolescents by 5
to 1.5 Histological subtypes vary between adult
and  paediatric  populations.  Bronchial  carci-
noid  tumours  represent  50-80%  of  all  pul-
monary neoplasms diagnosed in children and
adolescents2,4,6,7 and small cell and squamous
cell lung cancers, common in adults are rare.2
Historically,  retrospective  population  based
studies have demonstrated lower overall sur-
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vival  in  younger  patients  with  lung  cancer
although more recent data suggests that when
stage is controlled for, overall and progression
free survival is similar.8 However, survival is
markedly  influenced  by  histology.  In  a  large
case series examining 160 patients less than
20 years old diagnosed with lung cancer, ade-
nocarcinoma  and  squamous  cell  carcinomas
were associated with the poorest survival with
a median survival of 14 months, in contrast,
those with endocrine neoplasms had a 92% 10
year survival.4
An additional unusual feature of this case
was the clinical and radiological features sug-
gestive of HOA. HOA is well documented in
adults but rarely encountered in children. The
clinical features include clubbing of the fin-
gers and toes, arthritis and a painful ossifying
periostitis of the tubular bones.1 HOA may be
primary (hereditary or idiopathic) or second-
ary. Most cases encountered in children and
young  adults  are  secondary  and  associated
with chronic suppurative lung processes (e.g.
cystic fibrosis), congenital heart disease and
biliary atresia. The association with malignan-
cy  is  relatively  common  in  adults  and  the
prevalence of HOA in lung cancer has recently
been reported in 4.5% of patients9,10 with over
80%  of  all  secondary  HOA  in  adults  due  to
malignancy.11,12 Malignancy-associated HOA in
children  and  young  adults  is  not  well  docu-
mented but there are a number of case reports
describing the association with carcinoma of
the  nasopharynx,  osteosarcoma,  rhab-
domyosarcoma  Hodgkin's  lymphoma,  thymic
carcinoma and pleural mesothelioma.13,14 We
did  not  identify  any  reported  cases  of  HOA
associated with lung carcinoma in children or
young adults in the literature. The exact patho-
genesis of HOA is not well understood. It has
been suggested that processes which disrupt
the pulmonary circulation prevent the normal
fragmentation of platelets within the capillary
bed. This allows the megakaryocytes or large
platelet clumps to enter the systemic circula-
tion where they can travel to the extremities
and  release  platelet  derived  growth  factor
(PDGF) which leads to vascular proliferation,
oedema  and  new  bone  formation.15 Vascular
endothelial  growth  factor  (VEGF)  is  also
thought  to  contribute  to  the  development  of
HOA.  It  is  over  expressed  in  hypoxia  and
malignancy16 and like PDGF can induce vascu-
lar hyperplasia, new bone formation and oede-
ma.17 The management and prognosis of HOA
is  dependent  on  the  underlying  disease
process.  In  malignant  HOA  symptoms  often
resolve  with  the  removal  of  the  tumour  or
treatment  with  chemotherapy  as  in  this
case.14,18 Conventional analgesics, particularly
non-steroidal  anti-inflammatories  are  often
used  and  intravenous  bisphosphonates  have
been shown to improve symptoms.19A re-emer-
gence  of  symptoms  often  heralds  disease
relapse and may precede symptoms from the
primary tumour.14,20
Conclusions
Both primary lung cancer and HOA associat-
ed with malignancy are rare in children and
young  people  and  symptoms  may  often  go
unrecognised. Due to the small number of pri-
mary lung tumours in paediatric and adoles-
cent patients, delays at diagnosis are common
and patients often present with advanced stage
disease as in this case.
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